## OMCL: Omnicell, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 2.2% below STRENGTH zone (3.0-6.0%); PEG 2.28 fails VALUE criteria (<1.0); RSI 70 overbought. Stock is in no-man's land without clear edge. Caution: overbought RSI (70).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($43.97)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bearish (Bullish: 0, Bearish: 0)

**1. Voya Investment Management LLC Cuts Stock Position in Omnicell, Inc. $OMCL**
- Source: MarketBeat | 20260104T130941 | Somewhat-Bearish | Relevance: 100%
- Voya Investment Management LLC significantly reduced its stake in Omnicell, Inc. (NASDAQ:OMCL) during the third quarter, selling 35,694,801 shares and now holding 14,167 shares valued at $431,000. Despite this, institutional ownership remains high at 97.70%, with several other funds adjusting their positions. Analyst ratings for Omnicell are mixed, with a consensus "Hold" rating and a $43.00 target price.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Wells Fargo | $52 | $43 | +21% |
| 2025-12-09 | B of A Securiti | $46 | $36 | +28% |
| 2025-12-09 | Benchmark | $50 | $45 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Wells Fargo | main | Overweight |
| 2025-12-09 | B of A Securiti | main | Neutral |
| 2025-12-09 | Benchmark | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 10 ($2.25M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Blackrock Inc.: 17.1% (-2.3%)
- Vanguard Group Inc: 12.5% (-0.4%)
- Dimensional Fund Adv: 5.3% (+9.1%)
- Cadian Capital Manag: 4.7% (+25.9%)
- State Street Corpora: 4.6% (-2.0%)

### Key Risks

1. Elevated short interest (8.9%): bears positioning against stock.
2. Overbought RSI (70) with bearish MACD signals exhaustion.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +20%) could attract flows.
- Momentum building: MRS_10 improving +2.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.28 elevated, pricing in significant growth expectations. Forward P/E 25.5x stretched relative to 8% growth. Analyst sentiment positive (3 raises, avg +20%). Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $2.2B |
| Beta | 0.78 |
| 52W Range | $22.66 - $47.69 |
| Short Interest | 8.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.28 |
| Forward P/E | 25.5 |
| Current P/E | 27.4 |
| YoY Growth | 7.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from 0.2% to 2.2% (+2.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.8pp (needs >3.0% for momentum thesis). MRS_5 at 2.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 70, risk of mean reversion. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.22% (CS: 70) | Neutral |
| RSI_14 | 70.2 | Overbought |
| MACD Histogram | -0.29 | Bearish |
| vs SMA20 | 1.045x | Above |
| vs SMA50 | 1.204x | Above |
| vs SMA200 | 1.437x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $46.93
- **Stop Loss:** $43.97 (6.3% risk)
- **Target:** $49.89 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 291
- **Position Value:** $13,656.63
- **Portfolio %:** 13.66%
- **Risk Dollars:** $862.50
- **Risk Per Trade:** 0.86%
- **Modifiers:** L1 115% | L2 75% | Combined 0.86x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-05 (Est: $0.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.36 | $0.51 | +40.7% |
| 2025Q2 | $0.27 | $0.45 | +66.7% |
| 2025Q1 | $0.20 | $0.26 | +27.1% |
| 2024Q4 | $0.58 | $0.60 | +2.8% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_10*